Muse Capital has launched the 'Optima Program,' a unique initiative that pairs female athletes and sports executives with a curated selection of women's health companies across 10 categories.
The program debuted alongside the Red Bull Italy SailGP Team and focuses on areas such as hormone tracking, fertility support, mental health and performance-specific products that are typically absent from women's sports environments. Partner brands include Midi Health, Eli Health, Cofertility, BeSound and Sequel. Each company was selected to address the biological and performance needs that traditional sports science doesn't cover.
As investments in women's professional sports continue to grow, Muse Capital's program shows how purpose-built health platforms can move beyond research and deliver real, accessible tools for athletes.
Female Athlete Wellness Programs
Muse Capital Launched Its Optima Program for Sports Performance
Trend Themes
1. Purpose-built Women's Health Platforms - Growing demand for platforms tailored to female athletes highlights opportunities to create end-to-end ecosystems that integrate fertility, hormone and mental health services with performance programs.
2. Data-driven Hormone and Cycle Tracking - Emergence of precise, athlete-grade hormone monitoring suggests potential for personalized training regimens and product lines optimized for menstrual cycle phases and reproductive health needs.
3. Branded Sports-health Partnerships - Integration of startups with professional teams points to novel co-branded models where sports franchises and health companies jointly develop and commercialize athlete-specific solutions.
Industry Implications
1. Sports Technology - Advanced wearable and analytics systems designed for female physiology could redefine performance measurement and create new product categories focused on cycle-aware training.
2. Women's Health and Fertility Care - Clinical and consumer health services that combine fertility support with performance medicine may disrupt traditional care pathways by centering athlete-specific biological needs.
3. Venture Capital in Women's Sports - Targeted investment vehicles capitalizing on underserved female athlete markets could accelerate commercialization of niche health technologies and reshape funding priorities in sports innovation.